Recent Finacing
Recent Raise
Rhenovia Pharma builds biosimulation platforms predicting molecular effects in healthy individuals and neurological patients, assessing neurotoxicity from pesticides, nanoparticles, industrial emissions and chemical agents, and supporting antidote and drug development.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors